WhaleCreep

Which hedge funds own PLX? PROTALIX BIOTHERAPEUTICS INC, Q2 2026 13F holders

HealthcareBiotechnology

10 tracked hedge funds disclosed a position in PLX (PROTALIX BIOTHERAPEUTICS INC) in their Q2 2026 13F filings, worth $5.9m in total. The largest holder by portfolio weight is Hillsdale Investment Management Inc. at 0.0% of its book. 6 opened a new position this quarter: Hillsdale Investment Management Inc., Marshall Wace, LLP, Citadel Advisors LLC, Millennium Management LLC. 3 exited: Mak Capital One LLC, Opaleye Management Inc., Diametric Capital, LP.

10
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
6
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
3
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$2.8m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$8.7m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$5.9m
Combined value
Sum of the holders' reported positions in the security.
0.8%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.

Holders, Q2 2026

10 rows
Hillsdale Investment Management Inc. Hedge fund0.01%$433k185,711–new
Prelude Capital Management, LLC Hedge fund0.0%$52.9k22,700+20%added
Renaissance Technologies LLC Hedge fund0.0%$2.6m1.10m−11%reduced
Marshall Wace, LLP Hedge fund0.0%$1.1m452,757–new
Citadel Advisors LLC Hedge fund0.0%$779k334,227–new
Millennium Management LLC Hedge fund0.0%$400k171,535–new
Walleye Capital LLC Hedge fund0.0%$46.2k19,839–new
AQR Capital Management LLC Hedge fund0.0%$391k167,826+450%added
Point72 Asset Management, L.P. Hedge fund0.0%$59.6k25,566–new
Two Sigma Investments, LP Hedge fund0.0%$99.1k42,515+135%added